To describe Carfilzomib utilization of KRd and Kd in routine clinical practice in APAC, including treatment patterns, patient profile and reasons for discontinuation
Latest Information Update: 04 Aug 2021
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide; Daratumumab; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2021 New trial record
- 17 Jun 2021 Interim results (as of 10 September 2020; n= 126) presented at the 26th Congress of the European Haematology Association